Since inception, a total of 964 projects executed successfully (1/5.5 days, most with PGS improvements). The successful delivery rate is >99% with numerous significant breakthroughs and improvements.
3 cGMP projects, 200 g, 300 g and 1 kg executed successfully in 2011, 2012
Phase II Project: A highly reliable, efficient process has been developed, total 800 kg delivered on time on spec.
API intermediate: A challenging difluro-compound, high value, a practical, scalable economic process developed, 1 kg and 10 kg delivered on time.
Phase II Intermediate: Process research, a new asymmetric route established, >99% ee (originally 95%), the new cost is 25% reduction.
Phase I Project: Asymmetric H2, 7 kg delivered with >99.5% ee, leading to an order of 64 kg, also delivered.
A drug intermediate, 27 kg. Grignard reaction involved. 2 months project, delivered in 1.5 months with significant process improvements regarding safety, reaction cycle and solvents.
Two drug intermediates, 3 kg each. NaHCO3 used to replace NaHMSD and BuLi. 2 months project, completed in 1.5 months. Major improvements achieved in 1-2 weeks.
A cancer drug intermediate, 13-step synthesis, overall yield 0.5%, after PGS work, a economic, scalable process developed, overall yield increased to 4.8% from 2.7%, scaled-up up 160 kg output .